CAMBRIDGE, Mass., February 07, 2025--eGenesis announces second patient successfully transplanted with genetically engineered ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

In a significant development for organ transplantation, two U.S. biotechnology companies, United Therapeutics and ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

Eledon Pharmaceuticals (ELDN) announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the ...

It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as part of a new clinical trial sanctioned by the Food and Drug Administration.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.